Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS

Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection

NCT00001386 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected Adults

NCT02178800 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure

NCT03758625 ·Status: COMPLETED ·Phase: PHASE1

A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease

NCT00205231 ·Status: COMPLETED ·Phase: NA

A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.

NCT00000846 ·Status: COMPLETED ·Phase: PHASE1

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

NCT00000820 ·Status: COMPLETED ·Phase: PHASE2

Vaccine Treatment for HIV-Infection

NCT00108654 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults

NCT01783977 ·Status: COMPLETED ·Phase: PHASE1

N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV

NCT04144335 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption

NCT04340596 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Phase I Study of Vaccination Schedule of Experimental HIV Vaccines

NCT00321061 ·Status: COMPLETED ·Phase: PHASE1

Proof of Principle Study of Pulse Dosing of IL-15 to Deplete the Reservoir in HIV Infected People

NCT02191098 ·Status: COMPLETED ·Phase: PHASE1

HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs

NCT00056758 ·Status: COMPLETED ·Phase: PHASE1

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

NCT00058734 ·Status: COMPLETED ·Phase: PHASE1

Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients

NCT00001357 ·Status: COMPLETED ·Phase: PHASE2

Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People

NCT00053430 ·Status: COMPLETED ·Phase: PHASE2

A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)

NCT00000804 ·Status: WITHDRAWN ·Phase: NA

Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United States

NCT03382418 ·Status: COMPLETED ·Phase: PHASE1

Selection of a Protective T Cell-based HIV-1/FIV Vaccine

NCT02389595 ·Status: ACTIVE_NOT_RECRUITING

Therapeutic Vaccine for HIV

NCT01859325 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating Vaccine in Adults With HIV

NCT00195234 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults

NCT00270218 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection

NCT00002441 ·Status: COMPLETED ·Phase: PHASE3

Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults

NCT00061243 ·Status: UNKNOWN ·Phase: PHASE1

Evaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected Adults

NCT02207920 ·Status: COMPLETED ·Phase: PHASE1